Theme 13 Clinical management and support

Acknowledgments:

This study was supported by the 2017 Motor Neurone Disease Research Institute of Australia Graham Lang Memorial grant-in-aid. We would like to thank the participants who took part in this study.

Acknowledgments:

The Motor Neurone Disease Research Institute of Australia 2017 Graham Lang Memorial grant-in-aid supported this study. We would like to thank the participants who took part in the interviews.

Acknowledgments:

Funded by the HRB Ireland and RMN under the MRCG-HRB scheme 2018.

Thanks to the respondents

Acknowledgments:

Brazilian National Council for Scientific and Technological Development (401922/2014-6; 381111/2018-0; 381142/2018-3). The authors declare no conflicts of interest.

Acknowledgments:

ALS Canada provided funding for this project.

Acknowledgments:

This study was supported by Grant from the Ministry of Health, Labour and Welfare of Japan

Acknowledgments:

We would like to thank the research participates in our study.

Funding: This research was supported in part by a grant from the Yuumi Memorial Foundation for Home Health Care

Acknowledgments:

This research project was a collaboration between Calvary Health Care Bethlehem and the University of Melbourne.

Acknowledgments:

The physiotherapy staff at CHCB for collecting this data.

Acknowledgments:

R Francis is a recipient of The Australian Government Research Training Program Scholarship and the MND Victoria 24th Nina Buscombe Award.

Acknowledgments:

We would like to acknowledge the Harper’s Hope Fund for ALS at the Medical College of Virginia Foundation which helped to financially support this work. We would like to acknowledge our patient and their families for their commitment to bringing awareness of the disease.

Acknowledgments:

We would like to thank patients for taking part in the study. Funding for this study was provided by Aquestive Therapeutics. CB, CJ, and GS are employees of Aquestive. AHH served as a paid consultant to Aquestive.

Acknowledgments:

Supported by Muscular Dystrophy Association Care Center Grant, Atrium Health Foundation Carolinas ALS Funds as well as Pinstripes Foundation and ALS Charlotte Clinical Crew Funds.

Acknowledgments:

p-value communications provided editorial support. MTPA is providing funding for this study. The authors are employees of either MTPA (WA, JP, SA) or Soleo (BP).

Acknowledgments:

This study was sponsored by the Phil Smith Neuroscience Institute and Clinical Research Center.

Acknowledgments:

We would like to acknowledge the Harper’s Hope Fund for ALS at the Medical College of Virginia Foundation which helped to financially support this work. We would like to acknowledge our patient and their families for their commitment to bringing awareness of the disease.